دوره 11، شماره 4 - ( 8-1402 )                   جلد 11 شماره 4 صفحات 292-289 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghaffari J. Antihistamines in Pregnancy. J. Pediatr. Rev 2023; 11 (4) :289-292
URL: http://jpr.mazums.ac.ir/article-1-559-fa.html
Antihistamines in Pregnancy. Journal of Pediatrics Review. 1402; 11 (4) :289-292

URL: http://jpr.mazums.ac.ir/article-1-559-fa.html


چکیده:   (1802 مشاهده)
Allergic disorders are increasing prevalence from decades. Often of allergic diseases such as chronic urticaria in some aspects of quality of life of patients affected. Outdoor and indoor allergens can cause   aggravation of symptoms in allergic patients.
H1-antihistamines have been available for decades and those are over-the-counter drugs. The first generation H1-antihistamines have anticholinergic and sedative effects. Basically, their use (H1 blockers) for the routine management of allergic diseases is not recommended.  Second generation H1-antihistamines (bilastine, cetirizine, desloratadine, ebastine, fexofenadine, levocetirizine, loratadine, and rupatadine) have minimally or non-sedating and free of anticholinergic effects. About 10–15% of pregnant women used antihistamine within pregnancy.
متن کامل [PDF 271 kb]   (1636 دریافت)    
نوع مطالعه: Letter to the Editor | موضوع مقاله: آلرژی و ایمونولوژی بالینی
دریافت: 1402/5/31 | پذیرش: 1401/11/3 | انتشار: 1401/11/3

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Pediatrics Review می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb